XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity
 9 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders’ Equity

 

7. Stockholders’ Equity

  

Stock Options

 

The following table presents a summary of activity for all of our stock options:

          
       Weighted- 
       Average 
   Number of   Exercise Price 
   Shares   per Share 
   (In thousands)      
Balance of options outstanding at June 30, 2022   1,383   $3.40 
Granted   115    4.96 
Expired   (8)   1.84 
Exercised   (124)   2.94 
Balance of options outstanding at March 31, 2023   1,366   $3.59 

 

Restricted Stock Units (RSUs)

 

The following table presents a summary of activity with respect to our RSUs:

          
       Weighted- 
       Average 
       Grant Date 
   Number of   Fair Value 
   Shares   per Share 
   (In thousands)      
Balance of RSUs outstanding at June 30, 2022   1,115   $5.50 
Granted   701    5.69 
Forfeited   (76)   5.61 
Vested   (444)   5.38 
Balance of RSUs outstanding at March 31, 2023   1,296   $5.64 

 

Performance Stock Units (PSUs)

 

The following table presents a summary of activity with respect to our PSUs:

Stockholders Equity (Details - Schedule of PSU activity)

   Number of Shares 
   (In thousands) 
Balance of PSUs outstanding at June 30, 2022   1,030 
Granted   1,147 
Forfeited   (38)
Vested   (947)
Balance of PSUs outstanding at March 31, 2023   1,192 

 

Employee Stock Purchase Plan (ESPP)

 

The following table presents a summary of activity under our ESPP:

Stockholders Equity (Details - Schedule of ESPP activity)

   Number of 
   Shares 
   (In thousands) 
Shares available for issuance at June 30, 2022   85 
Reserved for issuance   500 
Shares issued   (92)
Shares available for issuance at March 31, 2023   493 

 

Share-Based Compensation Expense

 

The following table presents a summary of share-based compensation expense included in each functional line item on our accompanying unaudited condensed consolidated statements of operations:

                    
   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2023   2022   2023   2022 
   (In thousands) 
Cost of revenue  $47   $80   $159   $280 
Selling, general and administrative   1,293    1,264    4,132    3,568 
Research and development   388    268    1,090    745 
Total share-based compensation expense  $1,728   $1,612   $5,381   $4,593 

 

The following table presents the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of March 31, 2023:

          
   Remaining   Remaining 
   Unrecognized   Weighted- 
   Compensation   Average Years 
   Expense   To Recognize 
   (In thousands)      
Stock options  $499    2.6 
RSUs   5,897    2.3 
PSUs   2,954    2.1 
Stock purchase rights under ESPP   60    0.1 
   $9,410      

 

If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation will increase to the extent that we grant additional share-based awards.